Maheswari Rajasekaran, Ph.D. - Publications
Affiliations: | 2011 | Interdisciplinary Biomedical Sciences | University of Arkansas for Medical Sciences, United States |
Area:
PharmacologyYear | Citation | Score | |||
---|---|---|---|---|---|
2015 | Anthony Jalin AM, Rajasekaran M, Prather PL, Kwon JS, Gajulapati V, Choi Y, Kim C, Pahk K, Ju C, Kim WK. Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity. Plos One. 10: e0141600. PMID 26517721 DOI: 10.1371/Journal.Pone.0141600 | 0.582 | |||
2013 | Rajasekaran M, Brents LK, Franks LN, Moran JH, Prather PL. Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. Toxicology and Applied Pharmacology. 269: 100-8. PMID 23537664 DOI: 10.1016/J.Taap.2013.03.012 | 0.568 | |||
2012 | Seely KA, Brents LK, Franks LN, Rajasekaran M, Zimmerman SM, Fantegrossi WE, Prather PL. AM-251 and rimonabant act as direct antagonists at mu-opioid receptors: Implications for opioid/cannabinoid interaction studies Neuropharmacology. 63: 905-915. PMID 22771770 DOI: 10.1016/J.Neuropharm.2012.06.046 | 0.39 | |||
Show low-probability matches. |